Roivant Sciences Ltd. - 10%+ Owner at Arbutus Biopharma Corp

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
ABUS on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Roivant Sciences Ltd. since 05 Sep 2025

Reported holdings for Roivant Sciences Ltd. in Arbutus Biopharma Corp

Form 4 holding 10%+ Owner

Arbutus Biopharma Corp

Security class
Common shares, without par value
Shares / value
38,847,462
Estimated value
Report date
18 Oct 2021
Price
Ownership
Direct
Form 4 holding 10%+ Owner

Arbutus Biopharma Corp

Security class
Series A participating convertible preferred shares
Shares / value
0
Estimated value
Report date
18 Oct 2021
Price
Ownership
Direct
Underlying class
Common shares
Underlying amount

Transaction history for Roivant Sciences Ltd. in Arbutus Biopharma Corp

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .